Want to see DNTH full AI Analyst Report?
Dianthus Therapeutics (DNTH) Q4 2023 Earnings Report
DNTH Q4 2023 EPS Results
- Actual EPS
- -$0.71
- Consensus EPS
- -$0.94
- Beat/Miss
- Beat by +$0.23
- One Year Ago EPS
- -$4.80
DNTH Q4 2023 Revenue Results
- Actual Revenue
- $457.00K
- Expected Revenue
- $548.00K
- Beat/Miss
- Missed by -$91.00K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/21/2024
- Time
- After Close
- Conference Call
- Thursday, March 21, 2024
DNTH Upcoming Earnings
Dianthus Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q4 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DNTH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.94- | -0.97 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | -0.85-0.90 | -0.88 | -2.27% (-0.02) | |
| May 05, 2026 | 2026 (Q1) | -1.07-0.85 | -0.82 | -3.66% (-0.03) | |
| Mar 09, 2026 | 2025 (Q4) | -1.01-1.43 | -0.81 | -76.54% (-0.62) | |
| Nov 05, 2025 | 2025 (Q3) | -0.87-0.97 | -0.74 | -31.08% (-0.23) | |
| Aug 07, 2025 | 2025 (Q2) | -0.87-0.88 | -0.51 | -72.55% (-0.37) | |
| May 12, 2025 | 2025 (Q1) | -0.85-0.82 | -0.54 | -51.85% (-0.28) | |
| Mar 11, 2025 | 2024 (Q4) | -0.85-0.81 | -0.71 | -14.08% (-0.10) | |
| Nov 07, 2024 | 2024 (Q3) | -0.59-0.74 | -3.78 | 80.42% (+3.04) | |
| Aug 08, 2024 | 2024 (Q2) | -0.55-0.51 | -3.12 | 83.65% (+2.61) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
